The $47,000 IVF Cost Gap Between Cook County and Harris County Has Nothing to Do With Clinic Quality
The $47,000 IVF Cost Gap Between Cook County and Harris County Has Nothing to Do With Clinic Quality
The CDC's 2022 Assisted Reproductive Technology report shows a 47.6% live birth rate per egg retrieval nationally for women under 35. Clinics in Cook County, Illinois cluster around 51%. Clinics in Harris County, Texas sit near 48%. A three-point difference -- barely enough to notice, nowhere near enough to drive a decision.
Yet when you build out the full picture -- expected cycles, out-of-pocket exposure per cycle, and the age at which patients in each county actually begin treatment -- the expected total cost to achieve one live birth is roughly $31,000 in Cook County and $78,000 in Harris County. That is not a rounding error. It is a $47,000 structural gap, and it has almost nothing to do with which county has the better embryologists.
The driver is something most fertility cost calculators never touch: insurance mandate status shapes when patients start treatment, and maternal age at first retrieval is the single most powerful variable in IVF outcomes. County-level data makes this visible. National averages bury it completely.
The Metric Clinics Publish and the Metric That Actually Matters
Every fertility clinic in the United States reports to the CDC under the ART Surveillance system. The headline figure is live birth rate per egg retrieval cycle. It is accurate. It is also, for most patients, the wrong number to optimize on.
The metric that governs your financial exposure is expected total cost to live birth: the sum of all cycles -- retrievals, transfers, frozen embryo transfers, potential repeat retrievals -- weighted by success probability at each stage, multiplied by your out-of-pocket cost per cycle. For patients with full insurance coverage, the out-of-pocket component is small, and the total expected spend converges toward the co-pay structure. For patients with no mandate coverage, each retrieval runs $12,000 to $15,000 in direct costs before medications, which add another $3,000 to $6,000.
A clinic with a 51% success rate looks nearly identical to one running at 48% when you compute live birth rate per retrieval. But when you compound across multiple cycles -- which roughly 60% of patients require before achieving a live birth -- that three-point gap produces meaningfully different total-cost profiles. More importantly, it interacts with coverage: covered patients can absorb two or three cycles financially; uncovered patients often cannot.
This is where county geography enters the calculation in a way that individual clinic statistics simply cannot capture.
How Illinois and Texas Build Different Patient Populations
Illinois has mandated comprehensive infertility insurance coverage since 1991. The law requires large employer group plans to cover IVF, including up to four egg retrievals. RESOLVE's state-by-state breakdown confirms Illinois as one of the most expansive mandate states in the country.
Texas has no IVF mandate. Texas law requires only that carriers offer -- not cover -- a limited infertility benefit rider. Most employers do not purchase it.
The downstream consequence is not just that Chicagoans pay less per cycle. It is that the patient population entering Cook County clinics is structurally different from the one entering Harris County clinics, in ways that directly affect reported success rates and total cost exposure.
Research published in Fertility and Sterility found that insurance mandate states show meaningfully higher IVF utilization rates. More specifically, utilization rises most sharply among women aged 30 to 34 -- the age cohort that tends to delay seeking care in non-mandate states due to cost. In states without mandates, the median age at first IVF retrieval skews older, typically 35 to 37, as patients spend years trying less expensive alternatives first or saving enough to self-pay.
That age shift is catastrophic for outcomes. The CDC's own data shows live birth rate per retrieval falls from roughly 48% at age 33 to 38% at age 36 to 24% at age 39. A patient who begins her first retrieval at 34 in Cook County and a patient who begins her first retrieval at 37 in Harris County are not comparable populations. When you report success rates without controlling for this, the Harris County clinic looks competitive. When you control for age at first retrieval, the gap widens considerably.
The Age Delay Is Where the $47,000 Lives
Here is the arithmetic that the national average obscures.
A 34-year-old patient in Cook County with full mandate coverage has a roughly 50% per-cycle success rate and near-zero out-of-pocket per retrieval. Her expected spend to live birth is dominated by co-pays and deductibles -- typically $5,000 to $10,000 total across expected cycles. Even with two cycles, she reaches $15,000 to $20,000 all-in.
A 37-year-old patient in Harris County with no mandate coverage faces a 38% per-cycle success rate and $15,000 to $20,000 per retrieval. Across the average 2.4 cycles at that age and success rate, her expected total out-of-pocket exposure is $55,000 to $80,000 -- and that figure assumes she does not require donor eggs, which become statistically likely above age 38 and add $25,000 to $45,000 to the total.
The three-year age gap between these two patients is not random. It is a predictable output of mandate status. Patients with coverage seek care earlier because the financial risk of attempting treatment at 33 is low. Patients without coverage delay because $15,000 per cycle creates a real threshold decision: try to conceive naturally another year and save money, or spend now. Many wait. The biological clock does not wait with them.
When you aggregate this across all patients in a county and look at the county-level pattern -- average maternal age at first retrieval, average cycles per patient, average total spend -- the mandate states show a compressed age distribution clustered near the high-success window. Non-mandate counties show a fat tail of patients who entered treatment later than was optimal.
Explore the data for Cook County and Harris County at Feralyx to see how this plays out across the full clinic inventory in each market.
King County and the New York Case: Mandate Adoption Changes the Data Quickly
The Illinois pattern is not unique, and importantly, the age-distribution effect responds quickly to mandate adoption. New York expanded its IVF mandate in January 2020 to require insurers covering more than 100 employees to cover three cycles of IVF. KFF's coverage analysis documented the immediate utilization response: cycle volume in New York clinics increased substantially in the 18 months following mandate expansion, with the sharpest uptick in the 30-to-34 age cohort.
New York City clinics, concentrated in Manhattan and Kings County, saw their patient age distribution shift measurably in 2021 and 2022 as newly covered patients entered the funnel who previously would have deferred. By 2023, the CDC's ART data for New York clinics showed improved aggregate success rates -- not because the clinics got better, but because the population composition shifted toward younger, healthier eggs.
Washington state added a mandate requirement in 2024, effective January 2025. King County clinics will almost certainly show the same pattern over the next reporting cycle: younger patients entering the system, higher aggregate success rates, lower average cycles per patient. The clinics will not have changed. The math will have changed.
This is the cleanest evidence that county-level success rate comparisons across mandate and non-mandate geographies are not measuring clinic quality in isolation. They are measuring the combined output of clinic quality, patient age distribution, and coverage access -- three variables that move together in ways that a single headline number cannot separate.
What the Clinic Success Rate Doesn't Tell You About Your Situation
None of this is a criticism of fertility clinics or the CDC reporting framework. The ART surveillance system is genuinely useful, and the clinic-level data it produces is among the most transparent outcome reporting in American medicine. The issue is interpretation.
A 51% live birth rate per retrieval at a Cook County clinic and a 48% rate at a Harris County clinic do not mean the same thing to two otherwise identical 34-year-old patients, one of whom has employer-sponsored IVF coverage and one of whom does not. For the covered patient, a slightly lower success rate barely affects total expected cost. For the self-pay patient, a lower success rate means more cycles, and more cycles at $15,000 to $20,000 each means the total spend compounds rapidly.
The variable you actually need is not success rate per cycle. It is expected cycles per live birth at your specific age, combined with your out-of-pocket cost per cycle given your insurance situation, resolved at the county level where you are actually going to receive care.
For patients in states without mandates -- Texas, Florida, Georgia, Arizona -- this calculation deserves serious attention before the first consultation. The clinic that quotes you the highest success rate may not be the one that produces the lowest expected total spend, particularly if that clinic has a strong patient selection effect (younger patients, better ovarian reserve, referred from other clinics as a second opinion). Success rate is not independent of patient mix.
For patients in mandate states, the bigger variables shift to clinic-specific outcomes for your age and diagnosis, cycle monitoring protocols, and lab quality on the embryology side. The insurance leverage mostly equalizes the financial exposure.
The Decision the Data Actually Supports
The fertility industry presents IVF cost as a per-cycle number and success as a per-cycle percentage. Both framings are technically accurate and practically insufficient for anyone trying to plan a real treatment path.
The county-level pattern that emerges from aggregating CDC ART data with mandate status and utilization rates by age cohort points toward a different decision framework: optimize for age at first retrieval, not clinic prestige. If you are in a non-mandate state and you are 32 or 33 and you know fertility treatment is likely in your future, the expected-cost math for starting now -- even self-pay -- may be substantially better than waiting until 36 with a larger savings buffer. The savings erode when the per-cycle success rate drops and the expected number of cycles rises.
If you are choosing between clinics within a mandate state, the financial variable becomes largely neutralized and clinic quality metrics deserve full analytical weight: live birth rate per retrieval stratified by age and diagnosis, cancellation rate (a proxy for lab and protocol quality), and blastocyst development rate as reported to SART.
If you are weighing clinics across a state line that separates a mandate from a non-mandate jurisdiction, the math needs to include travel and lodging costs against the potential coverage difference. For some patients in border counties -- southern Illinois versus Missouri, northern New Jersey versus Pennsylvania -- the answer to crossing a state line for IVF is yes, and the math is not close.
The Feralyx county explorer layers mandate status, clinic-level CDC outcomes, and coverage structure by county so this calculation is not something you have to build in a spreadsheet at midnight. The data exists. The gaps it reveals are real, and for a decision of this magnitude, the $47,000 difference between counties is exactly the kind of number that deserves to be visible before you schedule your first consultation.
Related Analysis
Other Smart Technology Investments tools that bear on this decision: